Pharmaceutical

Syndicate content
Updated: 33 weeks 1 day ago

J&J unit recalls 16,000 bottles of Risperdal for “uncharacteristic odor”

Sun, 06/19/2011 - 18:02

Reports of “uncharacteristic odor” from bottles of Risperdal schizophrenia drug marketed by Johnson & Johnson (JNJ)’s Ortho-McNeil-Janssen Pharmaceuticals unit has led to the recall of nearly 16,000 R


read more

Ventiv Health to Acquire PharmaNet

Wed, 05/18/2011 - 15:53

Ventiv Health has announced that it will be acquiring PharmaNet very soon. PharmaNet has confirmed this report.


read more

Teva Acquires Taiyo

Mon, 05/16/2011 - 17:28

Reports claimed that Israel’s Teva Pharmaceutical Industries Ltd. have bought 57% stake of Taiyo, which is the third-largest drug manufacturer of Japan. This deal was settled for $460 million cash.


read more

Takeda Pharmaceutical Discusses Nycomed Takeover

Thu, 05/12/2011 - 23:18

Takeda Pharmaceutical is currently discussing negotiations to be able to buy its rival Nycomed for anywhere between 8 billion and 10 billion Euros, said a source with direct knowledge of the situation


read more

Teva Pharmaceutical Has New Moves Up Its Sleeves

Tue, 05/03/2011 - 19:59

The pharmaceutical giant, Teva Pharmaceuticals Ltd is of the view that the firm is now depending on high-risk and high-reward drugs for the purpose of overcoming their competition in the market.


read more

Tradjenta Tablets to Treat Type 2 Diabetes

Tue, 05/03/2011 - 17:58

The diabetics face difficulty in breaking down the carbohydrates as their body develops resistance against a protein, insulin, and are more likely to have a heart stroke, kidney problems, blindness an


read more

Teva to Purchase Cephalon for $6.8 Billion

Mon, 05/02/2011 - 20:22

A deal has been signed between the boards of Teva Pharmaceutical Industries Ltd. and Cephalon Inc, based in Frazer, Pennsylvania. Teva will purchase Cephalon for $6.8 billion.


read more

FDA warns against some use of Teva reflux drug

Sun, 04/17/2011 - 08:20

The U. S. Food and Drug Administration have stated that it has received reports of blockage problems when a generic acid reflux drug is administered by oral syringe or feeding tubes.


read more

Roche Hedgehog Inhibitor' Shrinks Basal Cancer Tumours

Sun, 04/03/2011 - 21:01

Roche Holding AG and Curis Inc.’s experimental cancer drug has been shown to prevent and shrink basal cell skin tumours in patients having basal cell nevus syndrome, a rare disease significantly incre


read more

Pfizer: $177 million Spent on Medical Purposes

Fri, 04/01/2011 - 20:26

To make sure that there is an adequate transparency in the system, a joint effort by the drug makers has been initiated, according to which each one of them will be required to disclose their expendit


read more

Greenstone Recalls Two Drugs for Labeling Errors

Thu, 03/31/2011 - 19:08

On March 26, Greenstone LLC, a subsidiary of Pfizer Inc, made a recall on two generic drugs because of a bottle labeling mishap from a third-party manufacturer.


read more

FrenchTribune Specials